Questions Arise as Hims & Hers (HIMS) Had Revenue Decline on a Sequential Basis
August 25, 2025
Hims & Hers (HIMS) had revenue decline on a sequential basis, with a slew of other news that could mean slowing demand.
Research Reports
Hims & Hers (HIMS) Introduces Hair Growth Gummies for Women to its Lineup
June 19, 2025
Hims & Hers (HIMS) continues to innovate new treatments, like NEW hair growth gummies that are specifically designed for women.
Hims & Hers (HIMS) Jumps as the Company Will Sell Nova Nordisk’s Wegovy
April 29, 2025
News that Hims & Hers (HIMS) will be selling the Wegovy weight loss treatment on its platform sent HIMS stock higher today.
Hims & Hers (HIMS) Stock Climbs on a Plethora of Good News & Results
December 17, 2024
Hims & Hers (HIMS) is an online pharmacy with doctors who prescribe drugs for weight loss, hair loss sexual issues, and more.
Hims & Hers (HIMS) Continues to Produce Exceptional Results; But Risks Remain
October 9, 2024
Hims & Hers (HIMS) is growing rapidly and profits have been picking up. But the company’s weight loss drug comes with scrutiny.
Hims & Hers (HIMS) is Becoming a Disruptor in Providing Digital Healthcare
May 30, 2024
Hims & Hers Helalth (HIMS) has been in the news for its weight loss drug. But this is just one of many health solutions HIMS provides.